(Q39142507)

PubMed publication ID

28017431

9 September 2017

title

WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

World Health Organization

13 May 2020

main subject

0 references

author

Peter G. Smith

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

13 May 2020

Vasee Moorthy

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

13 May 2020

4

Shabir A Madhi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

13 May 2020

2

Stephanie J Schrag

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

13 May 2020

Ajoke Sobanjo-ter Meulen

6

object named as

Ajoke Sobanjo-Ter Meulen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

13 May 2020

10

Johan Vekemans

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

13 May 2020

author name string

Miwako Kobayashi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

13 May 2020

Mark R Alderson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

13 May 2020

Carol J Baker

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

13 May 2020

David C Kaslow

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

22 December 2016

1 reference

PubMed publication ID

9 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

13 May 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

13 May 2020

issue

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

13 May 2020

page(s)

7307-7314

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Increased risk for group B Streptococcus sepsis in young infants exposed to HIV, Soweto, South Africa, 2004-2008(1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

High Incidence of Invasive Group B Streptococcal Infections in HIV-Exposed Uninfected Infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

The infectious origins of stillbirth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Recurrence of group B streptococci colonization in subsequent pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Incidence and severity of invasive Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus infections among pregnant and postpartum women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Correlates of protection of serotype-specific capsular antibody and invasive Group B Streptococcus disease in South African infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Maternal antibody at delivery protects neonates from early onset group B streptococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Risk factors for neonatal sepsis and perinatal death among infants enrolled in the prevention of perinatal sepsis trial, Soweto, South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Disease Burden of Group B Streptococcus Among Infants in Sub-Saharan Africa: A Systematic Literature Review and Meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Risk factors for Group B Streptococcus colonisation and disease in Gambian women and their infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Prevalence, Serotype Distribution and Mortality Risk Associated With Group B Streptococcus Colonization of Newborns in Rural Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Maternal group B Streptococcus-related stillbirth: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Incidence, etiology, and outcome of bacterial meningitis in infants aged <90 days in the United kingdom and Republic of Ireland: prospective, enhanced, national population-based surveillance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Group B streptococcal epidemiology and vaccine needs in developed countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Revisiting the Need for Vaccine Prevention of Late-Onset Neonatal Group B Streptococcal Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Epidemiology of Invasive Group B Streptococcal Disease in the United States, 1999-2005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Maternal antibody transfer in baboons and mice vaccinated with a group B streptococcal polysaccharide conjugate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Group B Streptococcus β-hemolysin/cytolysin breaches maternal-fetal barriers to cause preterm birth and intrauterine fetal demise in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Ascending group B streptococcal genital infection in the rabbit model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine: A Randomized Controlled Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Association between low concentrations of antibodies to protein alpha and Rib and invasive neonatal group B streptococcal infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Profile: PATH's Vaccine Development Global Program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Cost-effectiveness of a potential group B streptococcal vaccine program for pregnant women in South Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Regulatory considerations in the clinical development of vaccines indicated for use during pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Ethical considerations for designing GBS maternal vaccine efficacy trials in low-middle income countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Using the impact of pneumococcal vaccines on nasopharyngeal carriage to aid licensing and vaccine implementation; a PneumoCarr meeting report March 27-28, 2012, Geneva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Mind the gap: jumping from vaccine licensure to routine use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Twenty-five years of the WHO vaccines prequalification programme (1987-2012): lessons learned and future perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

Immunogenicity and protective efficacy of the alpha C protein of group B streptococci are inversely related to the number of repeats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.12.029

7 January 2021

inferred from DOI database lookup

Global Advisory Committee on Vaccine Safety, 15–16 June 2016

1 reference

12 December 2020

Epidemiology of group B streptococcal disease in the United States: shifting paradigms

1 reference

12 December 2020

Vaccines to prevent neonatal GBS infection

1 reference

12 December 2020

Experimental vaginal colonization and mother-infant transmission of group B streptococci in rats

1 reference

12 December 2020

10.1016/J.VACCINE.2016.12.029

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6892266&resulttype=core&format=json

13 May 2020

PubMed publication ID

28017431

1 reference